At least 7,000 doses of vaccines in Japan were discarded due to improper preservation. Is this just the tip of the iceberg?

　　China News Service, June 6-According to Singapore’s Lianhe Zaobao, citing Japanese media reports, Japan, which is stepping up its efforts to vaccinate the people with the new crown vaccine, has frequently made mistakes in the preservation of the vaccine.

According to case statistics published by local governments, more than 7,000 doses of vaccines have been invalidated since Japan imported vaccines.

Data map: A truck equipped with a screen for preventive measures against the new coronavirus drove through the Shibuya intersection in Tokyo.

　　The large-scale vaccination sites in Omuta Hospital in Fukuoka Prefecture and Kobe City each discarded more than 1,000 doses of the American Pfizer vaccine, which required low temperature control, at room temperature.

Pfizer vaccines were initially required to be stored at minus 75 degrees, and the Japanese authorities also instructed relevant agencies to set the temperature at minus 80 degrees.

　　However, Japan made a mistake in February shortly after importing the vaccine.

The Ministry of Health of Japan announced that there was a problem with the equipment of a large medical institution. When the staff discovered that the situation occurred, the temperature of the freezer containing 1032 vaccines was 27 degrees Celsius.

　　The report also revealed other recent incidents of vaccine use errors. For example, the Port of Tokyo diluted the vaccine to twice the prescribed amount and discarded 12 doses of the vaccine.

　　Some organizations are willing to admit their mistakes and disclose the accident on their own.

However, Japanese media pointed out that this is just the tip of the iceberg.

　　After the outbreak of the new crown epidemic, Japan preemptively ordered vaccines from major pharmaceutical companies in Europe and the United States.

Pfizer plans to supply 194 million doses by the end of 2021. In addition, Japan will be able to supply 50 million doses of Modena vaccine by September.

The contract signed between Japan and AstraZeneca shows that there are 120 million doses in stock. However, due to concerns about the side effects of thrombosis after vaccination, although the vaccine has been approved in Japan, the vaccine is currently included in the "extended use".